Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery. - Wikidata - awgldk - TriplyDB

Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.

Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.

http://www.wikidata.org/entity/Q30628099

about

To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas.The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review.Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.Factors associated with a higher rate of distant failure after primary treatment for glioblastoma.Neurosurgical oncology: advances in operative technologies and adjuncts.5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging.Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey Optimizing glioblastoma resection: intraoperative mapping and beyond.Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded.Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas.Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Mol Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment.Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results.Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.Optical-sectioning microscopy of protoporphyrin IX fluorescence in human gliomas: standardization and quantitative comparison with histology.Annexin 2A sustains glioblastoma cell dissemination and proliferation.Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery.Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery [corrected].5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.Evaluation of the risk of liver damage from the use of 5-aminolevulinic acid for intra-operative identification and resection in patients with malignant gliomas.The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature.Response to journal club: 5-aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging.Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.Fluorescence-Guided Surgery.With a Little Help from My Friends: The Role of Intraoperative Fluorescent Dyes in the Surgical Management of High-Grade Gliomas.A Phase 1 Dose-Escalation Study of Oral 5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a Newly Diagnosed or Recurrent High-Grade Glioma.Commentary: Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.Resection in glioblastoma: maximal or safe.False-positive inflammatory change mimicking glioblastoma multiforme under 5-aminolevulinic acid-guided surgery: A case report.Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer

P2860

Q27028189-7C158674-DA83-433D-BCD1-0FF02A01A39F Q28078505-5266F35E-2321-4EF9-8293-521FE650F046 Q30250298-B959F207-5DA9-470C-B981-D585445EA02C Q30405581-13BD1791-50EE-4AFC-97D7-F325A7384248 Q30679537-65FBB36A-5C08-473C-BF48-9EAAB166B368 Q30833619-524DDB20-DA44-49B6-B700-59F6D835CEF7 Q34387771-F56F84D7-5DB4-447B-9076-5E3F55324754 Q34515718-1F47F4A0-DD09-4FC8-A0CC-62E6CBBF14BC Q35385779-8200D12B-0D8D-4D3F-99AD-7710224F7341 Q36180449-CAC657C9-E931-4707-AF2F-0D384C6E98D9 Q36335573-3F93281A-5C79-45BD-B360-ACF5ED4E38FA Q36540727-F9B458EB-5388-4D8A-A603-FAC373F691CC Q36564218-F9473FE6-1287-44DF-BF30-FB359163F42F Q36756809-51572942-A529-46D4-8258-9577882479A3 Q37002080-885C0690-41D5-47B3-A3CD-EF347E2E4BF6 Q37295485-0398806F-649B-46F3-931B-BA48801FBFE1 Q37525571-7A9A43D6-2F83-474F-A9EE-C9F340FECA14 Q38504172-10673370-7976-45CF-BBF0-313913E5A58D Q38728989-50996B4A-77D4-4601-9E2C-FBD6F7F7B192 Q38840667-B0DBFFB0-58DB-427F-89FE-A89C6F614B99 Q38844368-60CA1FA7-1F3A-49CF-BC6B-0B6BA4ACB341 Q39273311-D79E91F5-4F39-4C87-9494-BA78318B4F17 Q44737792-7BC9D84B-F329-4B5A-BA92-4B0BA8574AC2 Q44927068-09755BAC-0D77-4AAC-AB6E-3AE5F7198A31 Q47367159-9C7DA181-41EE-4787-95FD-6E9F2E159BB7 Q47837824-A205B50D-E669-4371-8587-1F7A989DF8F0 Q47968808-B1705369-1C0D-4504-9894-0C48535092C1 Q48333568-5BBBF2AE-7335-4692-BABD-B4D065C378FE Q48374101-77C032B7-3F30-4320-9091-BE8A53DAA7BC Q48391949-3207FA4F-58D4-48D5-A55E-4F1B9D4700E3 Q48413806-4EE235BD-82F1-4713-B643-5B65C311E871 Q49472946-2A949949-47BB-4F04-9032-4361ED91287D Q50133684-1817BAAE-4CEA-4BED-AF3F-388399DE2F2A Q50175112-39D0021B-1B8B-4471-82F0-106A6ABED8B4 Q52146989-6991C31B-CC56-4890-89D8-019CC8A6E7AB Q54441181-46513923-611B-4771-8120-F6B8B8D310F9 Q55082983-D27ED8E6-A2FD-4B51-8711-B51E9F0B8C36 Q59135212-C5352242-FB6C-4A78-A1F4-932906A27B6C

P2860

Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.

http://www.wikidata.org/entity/Q30628099

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Prognostic value of residual f ...... levulinic Acid-guided surgery.

@ast

Prognostic value of residual f ...... levulinic Acid-guided surgery.

@en

type

label

Prognostic value of residual f ...... levulinic Acid-guided surgery.

@ast

Prognostic value of residual f ...... levulinic Acid-guided surgery.

@en

prefLabel

Prognostic value of residual f ...... levulinic Acid-guided surgery.

@ast

Prognostic value of residual f ...... levulinic Acid-guided surgery.

@en

P1433

Q30628099-0BA15587-F607-4BDE-9F07-9A6582DA452D

P1476

Q30628099-9081577F-13B7-4FBD-853E-84F0237EB509

P2093

Q30628099-2CD83F33-C63C-4219-9367-9C16D8368C90

Q30628099-2F38DB14-DCDD-4471-9157-CA2D4027E36A

Q30628099-46BFCAEC-5503-46E4-BB8E-E07EFCDABE66

Q30628099-8E5B31A2-6C57-48CC-A7B7-6630B0B1A054

Q30628099-B78B3D65-956E-49F8-9628-0AA9FE901B06

Q30628099-D20FAA85-7713-422F-A93D-957562FFF635

Q30628099-DD2B2FDF-5070-48FA-A596-E484F5E43424

P2860

Q30628099-01132CE1-BBBF-4A17-AF56-EAF4C42E88E5

Q30628099-024E03A6-2AD1-4AEB-936F-83332FE84521

Q30628099-0529B3B2-040E-4DC5-AD8F-9E857D420650

Q30628099-17BD55C7-9B0A-4AE3-94F8-CC7F46E601F9

Q30628099-1A70DD38-244B-4244-A0DB-18155965429C

Q30628099-23EE8F18-48FD-46C0-9856-8C5E504552EB

Q30628099-2DA9AE74-3240-4B4C-AC94-AF08D146F534

Q30628099-4CF29837-F22E-4295-B29D-D54ABAD2CD30

Q30628099-5A524227-A0F7-41FF-839B-8CE3C74DFD0E

Q30628099-6B497908-8EFC-422B-A501-1C80E6833A2A

P304

Q30628099-EA81C758-6A4E-4F7B-BB60-E30EEC197395

P31

Q30628099-62B2DFF3-75A5-4190-90A4-5A5828C5787B

P356

Q30628099-7F6AEBE4-E5FC-49CC-8343-3987AAB63B74

P407

Q30628099-6947D318-72F6-4A77-A926-4E1A587C36A7

P433

Q30628099-6BCB9992-BFB8-45CC-92DD-7F942203F05F

P478

Q30628099-85B3C793-9623-444E-8F78-614ECC004D6A

P577

Q30628099-7B23F37D-0602-41BD-831A-6BAC4EC1B51B

P698

Q30628099-9C49CE48-8996-4F51-908F-F95745C3DF36

P356

NEU.0B013E31828C3974

P1433

P1476

Prognostic value of residual f ...... levulinic Acid-guided surgery.

@en

P2093

Bartolomé Bejarano

http://www.w3.org/2001/XMLSchema#string

Eva Pay

http://www.w3.org/2001/XMLSchema#string

Guillermo Aldave

http://www.w3.org/2001/XMLSchema#string

Miguel A Idoate

http://www.w3.org/2001/XMLSchema#string

Miguel Marigil

http://www.w3.org/2001/XMLSchema#string

Ricardo Díez-Valle

http://www.w3.org/2001/XMLSchema#string

Sonia Tejada

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.

Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery

P304

915-20; discussion 920-1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1227/NEU.0B013E31828C3974

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23685503

http://www.w3.org/2001/XMLSchema#string